Clinical Trial Results: Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection [Phase 2]

View source ↗

Summary

Phase 2 trial results for Obeldesivir in children with RSV infection have been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Obeldesivir (Obeldesivir)

Snippet

Sponsor: Gilead Sciences | Conditions: RSV Infection | Phase 2 | Status: TERMINATED | Results posted: 2026-06-08